LX-4211 CAS 1018899-04-1
Introduction:Basic information about LX-4211 CAS 1018899-04-1, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
LX-4211 Basic information
| Product Name: | LX-4211 |
| Synonyms: | (2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-(methylsulfanyl)tetrahydro-2-H-pyran-3,4,5-triol;CS-1853;LX4211; LX 4211; LX4211; LX 4211;LX-4211;(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(Methylthio)tetrahydro-2H-pyran-3,4,5-triol;(5S)-Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-1-thio-beta-L-xylopyranoside;Sotagliflozin;LX4211/LX-4211 |
| CAS: | 1018899-04-1 |
| MF: | C21H25ClO5S |
| MW: | 424.94 |
| EINECS: | |
| Product Categories: | |
| Mol File: | 1018899-04-1.mol |
LX-4211 Chemical Properties
| Boiling point | 607.9±55.0 °C(Predicted) |
| density | 1.37±0.1 g/cm3(Predicted) |
| storage temp. | Store at -20°C |
| solubility | DMSO:84.0(Max Conc. mg/mL);197.67(Max Conc. mM) Ethanol:17.0(Max Conc. mg/mL);40.01(Max Conc. mM) |
| pka | 12.87±0.70(Predicted) |
| form | Powder |
| color | White to off-white |
| Optical Rotation | 35.7°(C=0.01g/mL, CHCL3, 20°C, 589nm) |
| InChIKey | QKDRXGFQVGOQKS-WFCPIQDQNA-N |
| SMILES | [C@@H]1(C2=CC=C(Cl)C(CC3=CC=C(OCC)C=C3)=C2)O[C@H](SC)[C@@H](O)[C@H](O)[C@H]1O |&1:0,19,22,24,26,r| |
Safety Information
| Uses | Sotagliflozin is used for the treatment of patients with type 1 diabetes mellitus. |
| Clinical Use | Two of the current SGLT-2 inhibitors (canagliflozin and LX-4211) have effects on SGLT-1. LX-4211 is a dual SGLT1/2 inhibitor and higher doses of canagliflozin transiently inhibit SGLT-1 in the gut due to high canagliflozin concentrations within the intestinal lumen during the period of drug absorption. |
| Synthesis | Sotagliflozin is a dual SGLT-1/SGLT-2 inhibitor which is currently under development by Lexicon Pharmaceuticals (phase III). It follows a similar strategy to ertugliflozin, i.e. aryl addition on an acyclic precursor. The synthesis starts from L-xylose 53, and the aryl moiety (same aryl moiety as for dapagliflozin) is introduced on an amide derivative (morpholine amide 54) via Grignard addition. A subsequent transformation leads to the sotagliflozin (Scheme 10). The overall yield of the synthesis is around 30%. Sotagliflozin synthesis |
| IC 50 | SGLT1; SGLT2 |
